Literature DB >> 9430273

Gender and smoking-related risk of lung cancer. The Copenhagen Center for Prospective Population Studies.

E Prescott1, M Osler, H O Hein, K Borch-Johnsen, P Lange, P Schnohr, J Vestbo.   

Abstract

Our aim was to compare risk of lung cancer associated with smoking by gender and histologic type. A total of 30,874 subjects, 44% women, from three prospective population-based studies with initial examinations between 1964 and 1992 were followed until 1994 through the National Cancer Registry. There were 867 cases of lung cancer, 203 among women and 664 among men. Rates among female and male never-smokers were similar, although confidence intervals around rates were wide. Rate ratios (RRs) increased with number of pack-years for both men and women to a maximum of approximately 20 in inhaling smokers with more than 60 pack-years of tobacco exposure. RRs did not differ much between men and women: adjusted for pack-years, age, and study population, the ratio between female and male smokers' RRs of developing lung cancer was 0.8 (95% confidence interval = 0.3-2.1). All histologic types were associated with smoking, with the largest RR seen for squamous cell carcinoma and anaplastic carcinoma. This prospective population-based study does not confirm previous reports from case-control studies of a higher relative risk in women than in men for lung cancer associated with smoking.

Entities:  

Mesh:

Year:  1998        PMID: 9430273

Source DB:  PubMed          Journal:  Epidemiology        ISSN: 1044-3983            Impact factor:   4.822


  26 in total

1.  Targeting the estrogen pathway for the treatment and prevention of lung cancer.

Authors:  Timothy F Burns; Laura P Stabile
Journal:  Lung Cancer Manag       Date:  2014-02-01

Review 2.  Lung cancer in never smokers: clinical epidemiology and environmental risk factors.

Authors:  Jonathan M Samet; Erika Avila-Tang; Paolo Boffetta; Lindsay M Hannan; Susan Olivo-Marston; Michael J Thun; Charles M Rudin
Journal:  Clin Cancer Res       Date:  2009-09-15       Impact factor: 12.531

3.  Retrospective cohort study of smoking and lung cancer incidence in rural prefecture, Japan.

Authors:  Yoneatsu Osaki; Mikizo Okamoto; Akihiko Kaetsu; Takuji Kishimoto; Akihiko Suyama
Journal:  Environ Health Prev Med       Date:  2007-07       Impact factor: 3.674

Review 4.  Systematic review with meta-analysis of the epidemiological evidence in the 1900s relating smoking to lung cancer.

Authors:  Peter N Lee; Barbara A Forey; Katharine J Coombs
Journal:  BMC Cancer       Date:  2012-09-03       Impact factor: 4.430

5.  A case-referent study of cancer mortality among sulfate mill workers in Sweden.

Authors:  E Andersson; S Hagberg; T Nilsson; B Persson; G Wingren; K Torén
Journal:  Occup Environ Med       Date:  2001-05       Impact factor: 4.402

6.  GSTP1 Ile105Val polymorphism is associated with lung cancer risk among Asian population and smokers: an updated meta-analysis.

Authors:  Chun-hua Xu; Qin Wang; Ping Zhan; Qian Qian; Li-Ke Yu
Journal:  Mol Biol Rep       Date:  2014-02-25       Impact factor: 2.316

Review 7.  Smoking cessation in women. Special considerations.

Authors:  K A Perkins
Journal:  CNS Drugs       Date:  2001       Impact factor: 5.749

8.  CYP1A1 exon7 polymorphism is associated with lung cancer risk among the female population and among smokers: a meta-analysis.

Authors:  Chun-hua Xu; Qin Wang; Qian Qian; Ping Zhan; Li-Ke Yu
Journal:  Tumour Biol       Date:  2013-07-07

9.  Exploring the impact of gender and reproductive status on outcomes in a randomized clinical trial of naltrexone augmentation of nicotine patch.

Authors:  C Neill Epperson; Benjamin Toll; Ran Wu; Zenab Amin; Kathryn A Czarkowski; Peter Jatlow; Carolyn M Mazure; Stephanie S O'Malley
Journal:  Drug Alcohol Depend       Date:  2010-06-19       Impact factor: 4.492

10.  Are women who smoke at higher risk for lung cancer than men who smoke?

Authors:  Sara De Matteis; Dario Consonni; Angela C Pesatori; Andrew W Bergen; Pier Alberto Bertazzi; Neil E Caporaso; Jay H Lubin; Sholom Wacholder; Maria Teresa Landi
Journal:  Am J Epidemiol       Date:  2013-02-20       Impact factor: 4.897

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.